Article

Characterization of cytotoxic compound from marine sediment derived actinomycete Streptomyces avidinii strain SU4

Research Scholar, Department of Biotechnology, Sathyabama University, Jeppiaar Nagar, Rajiv Gandhi Salai, Chennai-600 119, India.
Asian Pacific Journal of Tropical Biomedicine 10/2012; 2(10):770-3. DOI: 10.1016/S2221-1691(12)60227-5
Source: PubMed

ABSTRACT

In the search of novel anticancer compounds we have taken an initiative to isolate halophilic actinomycetes from Tamilnadu coast. Fifty-two actinomycetes were isolated from the coastal soil samples of Pulicat, Ennore, Muttukadu, and Veerampattinam. Out of 52 isolates only 10 were subjected to brine shrimp lethality assay and one of the most potent cytotoxic isolate, which is the inhabitant of Veerampattinam was studied further. Crude extract of the active isolate exhibited LC50 in 62.5 μg against Hep-2 cell line, < 250μg in VERO cell line. The crude extract was purified by TLC and then characterized by using GC-MS. The following compounds diisobutyl phthalate (16.82%) and 1,2-Benzenedicaarboxylic acid, Bis(2-ehtylehexyl) ester (65.26%) were found abundantly with retention time 15.645, 21.620 respectively. Morphological, cultural, physiological, biochemical assay and 16s rRNA sequencing results the active strain was identified as Streptomyces and closely related to the species Streptomyces coelicolor also submitted to GENBANK. It is inferred that Streptomyces coelicolor strain SU5 producing anticancer compounds and these may be processed further for its commercial application. This study clearly proves that the marine sediment derived actinomycetes with bioactive metabolites can be expected to provide high quality biological material for high throughout biochemical and anticancer screening programs.

Download full-text

Full-text

Available from: Masilamani Selvam, Apr 08, 2014
  • Source
    • "Dibutyl phthalate, the bioactive compound produced by Streptomyces albidoflavus 321.2, was reported by Roya et al. (2006). So far, characterization of cytotoxic phthalate from marine sediment derived actinomycete Streptomyces avidinii strain SU4 was reported (Sudha and Masilamani, 2012). Terephthalic acid had been isolated from marine Streptomyces sp. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Marine Streptomyces ruber EKH2 isolated from sediments of Bardawil Lake, Egypt, was found as a promising strain for producing bioactive metabolite(s) working against some virulent fish pathogens. Some biochemical and morphological characterizations of marine S. ruber EKH2 were carried out. Cell free culture showed activities against the tested pathogens ranging from 15 to 30 mm. Optimized conditions for maximum activities were observed at neutrality and temperature 28 °C against the tested strains. Two grams of the ethyl acetate crude extract from 10 L culture supernatant was chromatographically separated into three fractions and bioassayed. One major antibacterial compound was separated exhibiting MIC average 12.5 μg/ml. Phthalic acid was structurally suggested on the basis of gas chromatography–mass spectrum (GC–MS) and infrared spectrum (IR). Phthalate activities were compared with known standard antibiotics used in fish therapy and found to be superior. A slight toxicity of phthalate against brine shrimp (LC50 = 2800 μg/ml) was observed. Dealing with pan-drug resistant bacteria in fish therapy, this study confirmed that marine S. ruber EKH2 is potentially used for extracting phthalic acid as a novel bioactive and non-toxic agent for treating bacterial fish infections.
    Full-text · Article · Apr 2015 · Egyptian Journal of Aquatic Research
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Actinobacteria are important sources of compounds for drug discovery and have attracted considerable pharmaceutical, chemical, agricultural and industrial interests. Actinobacteriological research is still in its infancy in India. Early work on actinobacteria started in the 20th century and mostly focused on studying the diversity, identification and screening for antibiotics, enzymes and enzyme inhibitors. Exploration of diverse habitats for the isolation of actinobacteria, have yielded till date 23 novel species. Screening of actinobacteria for antagonistic activity, has led to the discovery of four novel antibiotics. Research on enzymes mostly covered lipases, amylases, proteases, endoglucanases, a-galactosidases, pectin lyases, xylanases, L-asparaginases, L-glutaminase and cellulases. Research on exploiting actinobacteria for other purposes such as production of enzyme inhibitors, single cell protein, bioemulsifier and biosurfactants is still in the experimental stage. This review compiles the work done in last few years, with an emphasis on actinobacterial diversity and bioprospecting for pharmaceutically important compounds like antibiotics, enzymes and other important applications. The chemical creativity and biotechnological potential of Indian actinobacterial strains are yet to be fully explored. A national strategy is required consistent with the opportunities provided by CBD-Nagoya protocol.
    Full-text · Article · Aug 2013 · Indian journal of experimental biology
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Actinobacteria are important sources of compounds for drug discovery, and has attracted considerable pharmaceutical, chemical, agricultural, industrial interests. Actinobacteriological research is still at its infancy in India. Early work on actinobacteria started in the 20th century and mostly focused on studying the diversity, identification and screening for antibiotics, enzymes and enzyme inhibitors. The chemical creativity and biotechnological potential of Indian actinobacterial strains are yet to be fully explored. A national strategy is required consistent with the opportunities provided by CBD-Nagoya protocol. Exploration of diverse habitats for the isolation of actinobacteria, have yielded till date 23 novel species. Screening of actinobacteria for antagonistic activity, has led to the discovery of four novel antibiotics. Research on enzymes mostly covered lipases, amylases, proteases, endoglucanases, α-galactosidases, pectin lyases, xylanases, L-asparaginases, L-glutaminase and cellulases. Research on exploiting actinobacteria for other purposes such as production of enzyme inhibitors, single cell protein, bioemulsifier and biosurfactants is still in the experimental stage. This review compiles the work done in last few years, with an emphasis on actinobacterial diversity and biospropecting for pharmaceutically important compounds like antibiotics, enzymes and other important applications.
    Full-text · Article · Aug 2013 · Indian journal of experimental biology
Show more